Machine learning methods for prediction of CDK-inhibitors.
Jayashree Ramana1, Dinesh Gupta
1Structural and Computational Biology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India.
Plos One
|October 23, 2010
Summary
Cyclin-dependent kinase inhibitors (CDKIs) regulate cell cycles and have diverse functions. A new PSSM-based SVM machine learning model accurately identifies CDKIs, offering a valuable tool for cancer and stem cell research.
Area of Science:
- Molecular Biology
- Biochemistry
- Computational Biology
Background:
- Cell cycle progression relies on cyclin/cyclin-dependent kinase (CDK) complexes, regulated by CDK inhibitors (CDKIs).
- CDKIs play critical roles beyond cell cycle regulation, including apoptosis, transcriptional regulation, cell fate, migration, and cytoskeletal dynamics.
- These diverse functions make CDKIs significant therapeutic targets for cancer and stem cell interventions.
Purpose of the Study:
- To develop and evaluate machine learning methods for accurate identification of CDKIs.
- To address the challenge of sequence heterogeneity in CDKIs that hinders traditional identification methods.
Main Methods:
- Utilized Support Vector Machine (SVM) and Artificial Neural Network (ANN) classifiers.
- Incorporated compositional features and Position-Specific Scoring Matrices (PSSMs) derived from CDKIs and non-CDKIs.
- Evaluated models using Leave-One-Out Cross-Validation and independent datasets.
Main Results:
- The PSSM-based SVM model demonstrated superior performance as a classifier in both evaluation stages.
- The developed model effectively identifies CDKIs despite their sequence heterogeneity.
Conclusions:
- Machine learning, particularly PSSM-based SVM, offers a robust approach for identifying CDKIs.
- A user-friendly web interface (http://bioinfo.icgeb.res.in/cdkipred) is available for public use, facilitating CDKIs identification in research.
Related Concept Videos
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.